Circulating antiganglioside antibodies are not associated with the development of progressive disease or cerebral atrophy in patients with multiple sclerosis

✍ Scribed by Gavin Giovannoni; Patricia R. Morris; Geoffrey Keir

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 184 KB
• Volume: 47
• Category: Article
• ISSN: 0364-5134
• DOI: 10.1002/1531-8249(200005)47:5<684::aid-ana27>3.0.co;2-o